Submitted by brian@noovo-cr… on Tue, 11/26/2019 - 05:48

The Pain Resource Nurse Committee at Lawrence + Memorial Hospital's seminar:

The Use of Low dose Naltrexone (LDN) as a Treatment Option for Chronic Pain & Other Inflammatory/ Autoimmune Conditions

The seminar examined the specific conditions for which LDN has been shown to be an effective: non-opioid treatment option for patients experiencing moderate to severe pain, including Complex Regional Pain Syndrome (CRPS), fibromyalgia, neuropathies, back pain, and autoimmune disease. In addition, LDN’s unique ability to control pain in opioid-dependent patients, and assist in the tapering and elimination of opioids, will be reviewed. Discussed was a comprehensive review of the current literature, its mechanism of action, as well as the clinical experience gained from the treatment of thousands of LDN patients, to form the clinical indication-specific dosing guidance and titration protocols which are essential to achieving therapeutic success for patients.

Presenters were:

Neel Mehta, MD

mehta.jpgNeel Mehta, MD, is the Medical Director of Pain Medicine at the Weill Cornell Pain Medicine Center-New York Presbyterian Hospital in New York City. He is also Assistant Professor of Clinical Anesthesiology at Weill Cornell Medical College. Dr. Mehta is board certified in both anesthesia and interventional pain medicine.
Dr. Mehta earned his medical degree from Tufts University School of Medicine in Boston, MA, and completed an internal medicine internship at Carney Hospital in Dorchester, MA. He then completed his anesthesia residency and fellowship in interventional pain medicine at Weill Cornell Medical Center-New York Presbyterian.

Sarah Zielsdorf, MD, MS – Medical and Researcher Advisor to the LDN Research Trust; Special Guest

Zielsdorf_0.jpgDr. Sarah Zielsdorf hails from Ohio, where she received her BA in Microbiology from Miami University with a minor in molecular biology and a concentration in oboe performance. She went on to earn an MS in Public Health, Microbiology, and Emerging Infectious Diseases from The George Washington University in Washington, DC where she published her thesis on improving laboratory emergency preparedness post 9/11. Dr. Zielsdorf graduated from Loyola University Chicago Stritch School of Medicine and completed her residency in Internal Medicine at Loyola University Medical Center and Edward Hines, Jr. VA Medical Center. She holds a membership in the Institute for Functional Medicine and is Board Certified in Internal Medicine.

Linda Elsegood – Founder, LDN Research Trust (Norwich, England)

linda.jpgThe LDN Research Trust Charity was founded in 2002 in the UK. Its primary aim is to raise awareness and to fund clinical trials of Low Dose Naltrexone for autoimmune diseases, cancer, and chronic pain.

Location: Lawrence + Memorial Hospital

Sponsor: Pharmacist Christian Stella from Precision Pharmacy 

Prescribing Naltrexone - Naltrexone Letter

Low Dose Naltrexone - Ultra Low Dose Naltrexone

precision_1_0.jpg

Special Offer from Imbue Botanicals

CBD_1_0.png